Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease
Abstract
Background:
Excessive use of fructose has been incriminated as a risk factor for hepatic steatosis. Procollagen type III N-terminal peptide (P3NP) is a marker for steatohepatitis. Thus, we aimed to assess fructose intake in obese children and its relation to nonalcoholic fatty liver disease (NAFLD) and P3NP.
Methods:
Fifty-five obese children were compared to 30 controls. All were subjected to dietary fructose and anthropometric assessment, fasting blood sugar (FBS), fasting insulin (FI) and homeostasis model assessment of insulin resistance (HOMA-IR), lipid profile, uric acid, alanine aminotransferase (ALT), P3NP and abdominal ultrasound.
Results:
Patients had higher fructose intake which was associated with increased NAFLD grade. There was an increase in P3NP with increased NAFLD grade. P3NP correlated positively with fructose intake (processed sources and total) and caloric intake.
Conclusions:
High fructose intake is associated with NAFLD and P3NP may serve as a marker of NAFLD in obese children with a proposed cutoff value of 8.5 ng/mL.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Marzuillo P, Grandone A, Perrone L, Miraglia Del Giudice E. Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease. World J Gastroenterol 2015;21:6444–50.10.3748/wjg.v21.i21.6444Suche in Google Scholar PubMed PubMed Central
2. Papandreou D, Andreou E. Role of diet on non-alcoholic fatty liver disease: an updated narrative review. World J Hepatol 2015;7:575–82.10.4254/wjh.v7.i3.575Suche in Google Scholar PubMed PubMed Central
3. Tanwar S, Trembling PM, Guha IN, Parkes J, Kaye P, et al. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitisin patients with nonalcoholic fatty liver disease. Hepatology 2013;57: 103–11.10.1002/hep.26030Suche in Google Scholar PubMed
4. Niemelä O, Risteli L, Parkkinen J, Risteli J. Purification and characterization of the N-terminal propeptide of human type III procollagen. Biochem 1985;232:145–50.10.1042/bj2320145Suche in Google Scholar PubMed PubMed Central
5. Bolarin DM, Azinge EC. Biochemical markers, extracellular components in liver fibrosis and cirrhosis. Nig Q J Hosp Med 2007;17:42–52.10.4314/nqjhm.v17i1.12541Suche in Google Scholar PubMed
6. Cole TJ. A chart to link child centiles of body mass index, weight and height. Eur J Clin Nutr 2002;56:1196–9.10.1038/sj.ejcn.1601473Suche in Google Scholar PubMed
7. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity; British children, 1965. Arch Dis Child 1966;41:454–71, 613–35.10.1136/adc.41.219.454Suche in Google Scholar PubMed PubMed Central
8. Schwandt P, Kelishadi R, Haas G. First reference curves of waist circumference for German children in comparison to international values: the PEP Family Heart Study. World J Pediatr 2008;4:259–66.10.1007/s12519-008-0048-0Suche in Google Scholar PubMed
9. Mederico M, Paoli M, Zerpa Y, Briceño Y, Gómez-Pérez R, et al. Reference values of waist circumference and waist/hip ratio in children and adolescents of Mérida, Venezuela: comparison with international references. Endocrinol Nutr 2013;60:235–42.10.1016/j.endonu.2012.12.003Suche in Google Scholar PubMed
10. Moreno LA, Fleta J, Mur L, Rodríquez G, Sarría A, et al. Waist circumference values in Spanish children-gender related differences. Eur J Clin Nutr 1999;53:429–33.10.1038/sj.ejcn.1600769Suche in Google Scholar PubMed
11. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.10.1136/adc.44.235.291Suche in Google Scholar PubMed PubMed Central
12. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.10.1136/adc.45.239.13Suche in Google Scholar PubMed PubMed Central
13. National High Blood Pressure Education Program. Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996;98:649–58.10.1542/peds.98.4.649Suche in Google Scholar
14. Dwyer JL. Dietary assessment in modern nutrition in health and disease, 12th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2003.Suche in Google Scholar
15. Food Frequency Questionnaire: University of Cambridge. EPIC-Norfolk: nutritional methods. Available at: http://www.srl.cam.ac.uk/epic/nutmethod/FFQ.shtml. Accessed on 2/4/2013.Suche in Google Scholar
16. Mahmoud KA, Armanious NN, Youssef SS, Abdullah RM, Said FS, et al. Dietary fructose. In: Hassan HA, Mosea W, Khadr S, editors. Health food guide for the Egyptian family, 4th edn. Cairo: National Institute of Nutrition, 2005.Suche in Google Scholar
17. National Nutrition Institute. Food composition tables for Egypt, 2nd ed. Cairo, ARE: National Nutrition Institute, 2006.Suche in Google Scholar
18. Soldin SJ. Uric acid, serum. In: Soldin SJ, Brugnara C, Wong EC, editors. Pediatric reference intervals, 6th edn. Washington, DC: AACC Press, 2007:270.Suche in Google Scholar
19. National Cholesterol Education Program (NCEP). Expert panel of blood cholesterol levels in children and adolescents. Highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:495–501.10.1542/peds.89.3.495Suche in Google Scholar
20. American Diabetes Association Standards of Care for Diabetes. Brief summary of screening and diagnosis of type 2 diabetes and its complications. Diabetes Care 2013;36:S1.Suche in Google Scholar
21. Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistery, 2nd ed. Philadelphia: W.B. Saunders Co, 1994.Suche in Google Scholar
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.10.1007/BF00280883Suche in Google Scholar PubMed
23. Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006;16:279–84.10.1016/j.numecd.2005.12.007Suche in Google Scholar PubMed
24. Tester J, Sharma S, Jasik CB, Mietus-Snyder M, Tinajero-Deck L. Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California. Diabetes Metab Syndr 2013;7:161–5.10.1016/j.dsx.2013.06.002Suche in Google Scholar PubMed
25. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:3.10.1053/gast.2002.35354Suche in Google Scholar PubMed
26. Singh AK, Amlal H, Haas PJ, Dringenberg U, Fussell S, et al. Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5. Kidney Int 2008;74:438–47.10.1038/ki.2008.184Suche in Google Scholar PubMed
27. Jia G, Aroor AR, Whaley-Connell AT, Sowers JR. Fructose and uric acid: is there a role in endothelial function? Curr Hypertens Rep 2014;16:434.10.1007/s11906-014-0434-zSuche in Google Scholar PubMed PubMed Central
28. Miller A, Adeli K. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 2008;24:204–9.10.1097/MOG.0b013e3282f3f4c4Suche in Google Scholar PubMed
29. Schaefer EJ, Gleason JA, Dansinger ML. Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J Nutr 2009;139:1257S–62S.10.3945/jn.108.098186Suche in Google Scholar PubMed PubMed Central
30. Friedland O, Nemet D, Gorodnitsky G, Wolach B, Eliakim A. Obesity and lipid profiles in children and adolescents. J Pediat Endocr Met 2002;15:1011–6.10.1515/JPEM.2002.15.7.1011Suche in Google Scholar PubMed
31. Kelishadi R, Mirmoghtadaee P, Najafi H, Keikha M. Systematic review on the association of abdominal obesity in children and adolescents with cardio-metabolic risk factors. J Res Med Sci 2015;20:294–307.Suche in Google Scholar
32. Aeberli I, Zimmermann MB, Molinari L, Lehmann R, l’Allemand D, et al. Fructose intake is a predictor of LDL particle size in overweight school children. Am J Clin Nutr 2007;86:1174–8.10.1093/ajcn/86.4.1174Suche in Google Scholar PubMed
33. Chung M, Ma J, Patel K, Berger S, Lau J, et al. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: asystematic review and meta-analysis. Am J Clin Nutr 2014;100:833–49.10.3945/ajcn.114.086314Suche in Google Scholar PubMed PubMed Central
34. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. Br Med J 2008;336:309–12.10.1136/bmj.39449.819271.BESuche in Google Scholar PubMed PubMed Central
35. Nguyen S, Choi HK, Lustig RH, Hsu CY. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr 2009;154:807–13.10.1016/j.jpeds.2009.01.015Suche in Google Scholar PubMed PubMed Central
36. Welsh JA, Sharma A, Cunningham SA, Vos MB. Consumption of added sugars and indicators of cardiovascular disease risk among US adolescents. Circulation 2011;123:249–57.10.1161/CIRCULATIONAHA.110.972166Suche in Google Scholar PubMed PubMed Central
37. Arslan N, Tokgoz Y, Kume T, Bulbul M, Sayın O, et al. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents. J Pediatr Endocr Met 2013;26:1141–7.10.1515/jpem-2013-0029Suche in Google Scholar PubMed
38. Sullivan JS, Le MT, Pan Z, Rivard C, Love-Osborne K, et al. Oral fructose absorption in obese children with non-alcoholic fatty liver disease. Pediatr Obes 2015;10:188–95.10.1111/ijpo.238Suche in Google Scholar PubMed PubMed Central
39. Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010;90:23–46.10.1152/physrev.00019.2009Suche in Google Scholar PubMed
©2016 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Editorial
- Non-alcoholic fatty liver disease in children and adolescents
- Original Articles
- Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children
- Ferritin level is associated with metabolic syndrome and elevated alanine aminotransferase in children and adolescents
- Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease
- Central diabetes insipidus: clinical profile that suggests organicity in Peruvian children: Lima – Peru 2001–2013
- Salivary flow rate, buffer capacity, and urea concentration in adolescents with type 1 diabetes mellitus
- Cortisol response to adrenocorticotropin testing in non-classical congenital adrenal hyperplasia (NCCAH)
- Efficacy of micellized vs. fat-soluble vitamin D3 supplementation in healthy school children from Northern India
- Growth curves for congenital adrenal hyperplasia from a national retrospective cohort
- The effects of type 1 diabetes mellitus on cardiac functions in children: evaluation by conventional and tissue Doppler echocardiography
- The association between single nucleotide polymorphisms of the Apelin gene and diabetes mellitus in a Chinese population
- Case Reports
- Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation
- A case of 46,XX dysgenesis and marked tall stature; the need for caution in interpreting array comparative genomic hybridization (CGH)
- Successful treatment of a child with a prolactin secreting macroadenoma with temozolomide
- Acknowledgment
- Acknowledgment
Artikel in diesem Heft
- Frontmatter
- Editorial
- Non-alcoholic fatty liver disease in children and adolescents
- Original Articles
- Serum vascular endothelial cadherin and thrombomodulin are markers of non-alcoholic fatty liver disease in children
- Ferritin level is associated with metabolic syndrome and elevated alanine aminotransferase in children and adolescents
- Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease
- Central diabetes insipidus: clinical profile that suggests organicity in Peruvian children: Lima – Peru 2001–2013
- Salivary flow rate, buffer capacity, and urea concentration in adolescents with type 1 diabetes mellitus
- Cortisol response to adrenocorticotropin testing in non-classical congenital adrenal hyperplasia (NCCAH)
- Efficacy of micellized vs. fat-soluble vitamin D3 supplementation in healthy school children from Northern India
- Growth curves for congenital adrenal hyperplasia from a national retrospective cohort
- The effects of type 1 diabetes mellitus on cardiac functions in children: evaluation by conventional and tissue Doppler echocardiography
- The association between single nucleotide polymorphisms of the Apelin gene and diabetes mellitus in a Chinese population
- Case Reports
- Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation
- A case of 46,XX dysgenesis and marked tall stature; the need for caution in interpreting array comparative genomic hybridization (CGH)
- Successful treatment of a child with a prolactin secreting macroadenoma with temozolomide
- Acknowledgment
- Acknowledgment